Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease.

Mol Genet Metab Rep · 2021 · PMC8408524 · PMID 34485083

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

a decreasing trendP = 0.067so close (0.05 < p ≤ 0.1)

Liver volume showed a decreasing trend from 0.88xN (95% CI, 0.84-0.92) to 0.84xN (95% CI, 0.80-0.89), P = 0.067, but it was not statistically significant.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.